Czechia· CZ-0290129
KYINSU
A insulin icodec und semaglutid product containing insulin icodec + semaglutide, registered in Czechia by Novo Nordisk A/S, Bagsvaerd. The same ATC class is registered in 6 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Insulin icodec und semaglutid is registered in 6 of 19 countries.
Countries holding a registration under ATC A10AE57 (insulin icodec und semaglutid), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 4 of them publish a price we can compare per daily dose
Insulin icodec und semaglutid · ATC A10AE57
6 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
The record
At a glance
SÚKL (Czech Republic)- Active substance
- INSULIN ICODEC + SEMAGLUTIDE
- Manufacturer
- Novo Nordisk A/S, Bagsvaerd
- Country
- Czechia (CZ)
- ATC code
- A10AE57
- ATC class
- Insulin Icodec und Semaglutid
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Insulin icodec und semaglutid in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandKyinsuNovo Nordisk A/S
- IrelandKyinsu (700 units + 2 mg)/mL solution for injection in pre-filled penNovo Nordisk A/S
- IcelandKyinsuNovo Nordisk A/S
- NetherlandsKyinsu (700 eenheden + 2 mg)/ml oplossing voor injectie in een voorgevulde penNovo Nordisk A.S.
- PolandKyinsuNovo Nordisk A/S
- SwedenKyinsu 700 IE/ml + 2 mg/ml Injektionsvätska, lösning i förfylld injektionspennaNovo Nordisk A/S
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Kyinsu
- Norway · Kyinsu
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c342274f-1a45-4ba5-aa23-459e4b7b15eb GET /v1/drugs/c342274f-1a45-4ba5-aa23-459e4b7b15eb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SOL PEP",
"source": "sukl",
"strength": "(700U+2MG)/ML",
"pack_size": "1X0,43ML",
"substance": "INSULIN ICODEC + SEMAGLUTIDE",
"cz_kod_sukl": "0290129",
"product_type": "BT",
"substance_codes": "22651,18647",
"registration_state": "R",
"registration_number": "EU/1/25/1992/001"
}See everything about insulin icodec und semaglutid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.